Nephros, Inc.
Contact: Vikki Oconnor
Web: http://www.nephros.com
E-Mail:
Address: 41 Grand Ave, Suite 200, River Edge, New Jersey 07661, USA
Phone: +1-(201)-3435202 | Fax: +1-(201)-3435207 | Map/Directions >>
Profile: Nephros, Inc. deals with therapies for end stage renal disease and immuno-compromised patients. We develop ultrapure water, which removes bacteria, viruses, fungi, parasites, and biological toxins such as ricins, anthrax, cryptosporidiums, and botulinum toxins. Nephros offers dual stage ultra filters that are based on medical-grade mid-dilution hemodiafilters. We provide Nephros DSU, which comprises of micron filter pore sizes that are designed to remove a broad spectrum of bacteria, viral agents and biological toxins. These toxins include salmonella, hepatitis, HIV, Ebola viruses, Legionella, fungi and E-colis. Our DSU is used to remove harmful substances. Our Nephros is used to develop mid-dilution hemodiafiltration, which is a unique and proprietary fluid management system that optimizes removal of renal toxins across the molecular spectrum. We produce Olpur MD 190™, which is a proprietary filter that is specifically designed for use in hemodiafiltration therapy. We supply post-dilution and pre-dilution diafiltration into one elegant and to use filter design.
FDA Registration Number: 3003337893
4 Products/Services (Click for related suppliers)
|
| • Hemodialysis systems |
| • High Permeability with/without Sealed Dialysate System (FDA Code: KDI / 876.5860) A high permeability hemodialysis system is a device intended for use as an artificial kidney system for the treatment of patients with renal failure, fluid overload, or toxemic conditions by performing such therapies as hemodialysis, hemofiltration, hemoconcentration, and hemodiafiltration. Using a hemodialyzer with a semipermeable membrane that is more permeable to water than the semipermeable membrane of the conventional hemodialysis system (876.5820), the high permeability hemodialysis system removes toxins or excess fluid from the patient's blood using the principles of convection (via a high ultrafiltration rate) and/or diffusion (via a concentration gradient in dialysate). During treatment, blood is circulated from the patient through the hemodialyzer's blood compartment, while the dialysate solution flows countercurrent through the dialysate compartment. In this process, toxins and/or fluid are transferred across the membrane from the blood to the dialysate compartment. The hemodialysis delivery machine controls and monitors the parameters related to this processing, including the rate at which blood and dialysate are pumped through the system, and the rate at which fluid is removed from the patient. The high permeability hemodialysis system consists of the following devices: |
| • Ultra Water Filters, Dual Stage |
| • Ultrapure Grade Water Purification Systems |
